Open AccessBurden of Proof for Tolvaptan in ADPKD
Author(s) -
Reem A. Mustafa,
Alan S.L. Yu
Publication year - 2018
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.00190118
Subject(s) - tolvaptan , autosomal dominant polycystic kidney disease , medicine , renal function , vasopressin antagonists , placebo , urology , kidney disease , kidney , intensive care medicine , vasopressin , pathology , antagonist , alternative medicine , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom